These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10503812)

  • 21. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
    Staatz CE; Goodman LK; Tett SE
    Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A drug interaction study between ticlopidine and cyclosporin in heart transplant recipients.
    Boissonnat P; de Lorgeril M; Perroux V; Salen P; Batt AM; Barthelemy JC; Brouard R; Serres E; Delaye J
    Eur J Clin Pharmacol; 1997; 53(1):39-45. PubMed ID: 9349928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switching between cyclosporin formulations. What are the risks?
    Olyaei AJ; deMattos AM; Bennett WM
    Drug Saf; 1997 Jun; 16(6):366-73. PubMed ID: 9241491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients].
    Sperschneider H; Wagner C; Korn A; Christians U
    Med Klin (Munich); 1997 Oct; 92(10):589-96. PubMed ID: 9446006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYP3A5 polymorphism effect on cyclosporine pharmacokinetics in living donor renal transplant recipients: analysis by population pharmacokinetics.
    Song J; Kim MG; Choi B; Han NY; Yun HY; Yoon JH; Oh JM
    Ann Pharmacother; 2012 Sep; 46(9):1141-51. PubMed ID: 22947591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dextran sulfate sodium-induced colitis and ginseng intervention altered oral pharmacokinetics of cyclosporine A in rats.
    Yang Y; Hu N; Gao XJ; Li T; Yan ZX; Wang PP; Wei B; Li S; Zhang ZJ; Li SL; Yan R
    J Ethnopharmacol; 2021 Jan; 265():113251. PubMed ID: 32810615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal evaluation of the pharmacokinetics of cyclosporin microemulsion (Neoral) in pediatric renal transplant recipients and assessment of C2 level as a marker for absorption.
    Trompeter R; Fitzpatrick M; Hutchinson C; Johnston A
    Pediatr Transplant; 2003 Aug; 7(4):282-8. PubMed ID: 12890006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of cyclosporin in organ transplant recipients.
    Akhlaghi F; Trull AK
    Clin Pharmacokinet; 2002; 41(9):615-37. PubMed ID: 12126456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of organic anion transporting polypeptide-mediated hepatic uptake is the major determinant in the pharmacokinetic interaction between bosentan and cyclosporin A in the rat.
    Treiber A; Schneiter R; Delahaye S; Clozel M
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1121-9. PubMed ID: 14617681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.
    Gruber SA; Gallichio M; Rosano TG; Kaplan SS; Hughes SE; Urbauer DL; Singh TP; Lempert N; Conti DJ; Stein DS; Drusano G
    J Clin Pharmacol; 1997 Jul; 37(7):575-86. PubMed ID: 9243350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients.
    Falck P; Midtvedt K; Vân Lê TT; Storehagen L; Holdaas H; Hartmann A; Asberg A
    Clin Pharmacokinet; 2009; 48(9):615-23. PubMed ID: 19725595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of oral terbinafine treatment on cyclosporin pharmacokinetics in organ transplant recipients with dermatophyte nail infection.
    Jensen P; Lehne G; Fauchald P; Simonsen S
    Acta Derm Venereol; 1996 Jul; 76(4):280-1. PubMed ID: 8869684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin.
    Mai I; Krüger H; Budde K; Johne A; Brockmöller J; Neumayer HH; Roots I
    Int J Clin Pharmacol Ther; 2000 Oct; 38(10):500-2. PubMed ID: 11073292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel.
    Britten CD; Baker SD; Denis LJ; Johnson T; Drengler R; Siu LL; Duchin K; Kuhn J; Rowinsky EK
    Clin Cancer Res; 2000 Sep; 6(9):3459-68. PubMed ID: 10999729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new microemulsion formulation of cyclosporin: pharmacokinetic and clinical features.
    Friman S; Bäckman L
    Clin Pharmacokinet; 1996 Mar; 30(3):181-93. PubMed ID: 8882300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I.
    Monchaud C; Marquet P
    Clin Pharmacokinet; 2009; 48(7):419-62. PubMed ID: 19691367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of clinically relevant drug interactions associated with tacrolimus.
    Christians U; Jacobsen W; Benet LZ; Lampen A
    Clin Pharmacokinet; 2002; 41(11):813-51. PubMed ID: 12190331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.
    Plosker GL; Foster RH
    Drugs; 2000 Feb; 59(2):323-89. PubMed ID: 10730553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
    Cvetkovic RS; Goa KL
    Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.